Antibodies which bind human collapsin
    31.
    发明授权
    Antibodies which bind human collapsin 失效
    结合人折叠蛋白的抗体

    公开(公告)号:US5416197A

    公开(公告)日:1995-05-16

    申请号:US136922

    申请日:1993-10-15

    CPC classification number: C07K16/18 C07K14/4703

    Abstract: Essentially pure human collapsin and its uses are disclosed. An isolated nucleic acid molecule that comprises a nucleotide sequence that is complementary to a nucleotide sequence that encodes a portion of human collapsin is disclosed. Antibodies that specifically bind to human collapsin and that inhibit its activity are disclosed. Methods of inhibiting the activity of collapsin, methods of inducing neurite outgrowth and methods of treating individuals suffering from nerve damage comprising the step of contacting neuronal cells with nucleic acid molecule that comprises a nucleotide sequence that is complementary to a nucleotide sequence that encodes a portion of human collapsin or comprising the step of contacting a neuronal cell with an antibody that specifically binds to human collapsin are disclosed. Methods of identifying compounds that inhibit the activity of human collapsin comprising the steps of contacting a neuronal cell with human collapsin in the presence of a test compound are disclosed.

    Abstract translation: 公开了本质上纯的人类崩解蛋白及其用途。 公开了一种分离的核酸分子,其包含与编码人collapsin的一部分的核苷酸序列互补的核苷酸序列。 公开了特异性结合人塌陷蛋白并抑制其活性的抗体。 抑制皱缩蛋白酶活性的方法,诱导神经突生长的方法以及治疗患有神经损伤的个体的方法包括使神经元细胞与核酸分子接触的步骤,该核酸分子包含与编码部分的核苷酸序列互补的核苷酸序列 公开了包含将神经元细胞与特异性结合人皱缩蛋白酶的抗体接触的步骤。 鉴定抑制人崩斑蛋白活性的化合物的方法,其包括在测试化合物存在下使神经元细胞与人凝血因子接触的步骤。

    Nucleic acid quantitation from tissue slides
    36.
    发明申请
    Nucleic acid quantitation from tissue slides 有权
    来自组织载玻片的核酸定量

    公开(公告)号:US20080050746A1

    公开(公告)日:2008-02-28

    申请号:US11893356

    申请日:2007-08-14

    Abstract: This invention provides methods of quantitating nucleic acids from problematic samples, such as aged samples, formalin fixed samples, paraffin embedded samples, samples with aneuploid cells, and cells with fragmented nucleic acids. Methods include techniques to efficiently solublize the nucleic acids under non-denaturing conditions from preserved clinical samples without resort to organic extractions, to normalize cell counts regardless of aneuploidy, to access the fragmentation state of the nucleic acids, and to provide standard curves for degraded nucleic acid samples.

    Abstract translation: 本发明提供了定量来自有问题样品的核酸的方法,例如老化样品,福尔马林固定样品,石蜡包埋样品,具有非整倍体细胞的样品和具有片段化核酸的细胞。 方法包括在非变性条件下有效地从保存的临床样品中纯化核酸而不用有机提取的技术,使细胞计数正常化而不管非整倍体,以获得核酸的断裂状态,并为降解的核酸提供标准曲线 酸样。

    Semaphorin K1
    37.
    发明授权

    公开(公告)号:US06583277B2

    公开(公告)日:2003-06-24

    申请号:US09771467

    申请日:2001-01-26

    CPC classification number: C07K14/4703 A61K38/00

    Abstract: The invention provides methods and compositions relating to semaphorin K1 (sema K1) polypeptides which regulate cellular guidance and physiology, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed sema K1 encoding nucleic acids or purified from human cells. The invention provides isolated sema K1 hybridization probes and primers capable of specifically hybridizing with the disclosed sema K1 genes, sema K1-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

    Semaphorin K1
    39.
    发明授权
    Semaphorin K1 失效
    信号素K1

    公开(公告)号:US06225285B1

    公开(公告)日:2001-05-01

    申请号:US09041236

    申请日:1998-03-11

    CPC classification number: C07K14/4703 A61K38/00

    Abstract: The invention provides methods and compositions relating to semaphorin K1 (sema K1) polypeptides which regulate cellular guidance and physiology, and related nucleic acids. The polypeptides may be produced recombinantly from transformed host cells from the disclosed sema K1 encoding nucleic acids or purified from human cells. The invention provides isolated sema K1 hybridization probes and primers capable of specifically hybridizing with the disclosed sema K1 genes, sema K1-specific binding agents such as specific antibodies, and methods of making and using the subject compositions in diagnosis, therapy and in the biopharmaceutical industry.

    Abstract translation: 本发明提供了与调节细胞指导和生理学的信号素K1(sema K1)多肽以及相关核酸相关的方法和组合物。 可以从所公开的编码核酸的半胱氨酸K1的转化的宿主细胞重组产生多肽或从人细胞中纯化多肽。 本发明提供了能够与所公开的半碱基K1基因,半胱氨酸K1特异性结合剂如特异性抗体特异性杂交的分离的半碱基K1杂交探针和引物,以及在诊断,治疗和生物制药行业中制备和使用受试者组合物的方法 。

Patent Agency Ranking